Profile
International Journal of Clinical Research & Trials Volume 2 (2017), Article ID 2:IJCRT-111, 4 pages
https://doi.org/10.15344/2456-8007/2017/111
Research Article
Open Label Clinical Trial of Hydrogen Brain Food for 91 Alzheimer's Patients (Targeting Therapy for Homocysteic Acid in Blood is an Alzheimer's Cognitive Recovery)

Tohru Hasegawa1* and Yasubumi Uchida2

1Saga Woman Junior College, Saga 849-8440, Japan
2Saga Memorial Hospital, Takagise, 849-0917, Saga, Japan
Dr. Tohru Hasegawa, Saga Woman Junior College ,1313 Honjomachi Oaza Honjo, Saga, Saga Prefecture 840-8440, Japan; E-mail: ghf238134@leo.bbiq.jp
06 December 2016; 10 January 2017; 12 January 2017
Hasegawa T, Uchida Y (2017) Open Label Clinical Trial of Hydrogen Brain Food for 91 Alzheimer's Patients (Targeting Therapy for Homocysteic Acid in Blood is an Alzheimer's Cognitive Recovery). Int J Clin Res Trials 2: 111. doi: https://doi.org/10.15344/2456-8007/2017/111

References

  1. Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10: 698-712 [CrossRef] [Google Scholar] [PubMed]
  2. Snowdon DA (1997) Aging and Alzheimer's Disease: Lessons From the Nun Study. Gerontologist 37: 150-156 [CrossRef] [Google Scholar] [PubMed]
  3. Stern Y (2012) Cognitive reserve in ageing and Alzheimer'sdisease. Lancet Neurol 11: 1006-1012 [CrossRef] [Google Scholar] [PubMed]
  4. Lockhart B, Jones C, Cuisinier C, Villain N, Peyroulan D, et al. (2000) Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with a-lipoic acid enantiomers. Brain Res 855: 292-297 [CrossRef] [Google Scholar] [PubMed]
  5. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, et al. (2007) Natural Oligomers of the AlzheimerAmyloid-s Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor- Dependent Signaling Pathway. J Neurosci 27: 2866-2875 [CrossRef] [Google Scholar] [PubMed]
  6. Folbergrová J, Jesina P, Drahota Z, Lisý V, Haugvicová R,et al. (2007) Mitochondrial complex Iinhibitionincerebralcortexof immature rats following homocysteic acid-inducedseizures. Exp Neurol 204: 597-609 [CrossRef] [Google Scholar] [PubMed]
  7. Ramos Coutinho M, da Silva LF, Menescal-de-Oliveira L (2008) Modulation of tonic immobility in guinea pig PAG by homocysteic acid, a glutamate agonist. Physiol Behav 94: 468-473 [CrossRef] [Google Scholar] [PubMed]
  8. Beard RS Jr, Reynolds JJ, Bearden SE (2011) Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptordependent regulation of adherens and tight junctions. Blood 118: 2007- 2014 [CrossRef] [Google Scholar] [PubMed]
  9. Vorbrodt AW, Dobrogowska DH, Ueno M, Tarnawski M (1995) A quantitative immunocytochemical study of blood-brain barrier to endogenous albumin in cerebral cortex and hippocampus of senescence-accelerated mice (SAM). Folia Histochem Cytobiol 33: 229-237 [Google Scholar] [PubMed]
  10. Scudellar M (2015) By splicing animals together, scientists have shown that young blood rejuvenates old tissues. Now, they are testing whether it works for humans. Nature 517: 426-429 [View]
  11. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, et al. (2011) The ageingsystemic milieu negatively regulates neurogenesis and cognitivefunction. Nature 477: 90-4 [CrossRef] [Google Scholar] [PubMed]
  12. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485: 512-516 [CrossRef] [Google Scholar] [PubMed]
  13. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, et al. (2015) Blood-Brain Barrier Breakdown in the Aging Human Hippocampus. Neuron 85: 296-302 [CrossRef] [Google Scholar] [PubMed]
  14. Hasegawa T, Ichiba M, Matsumoto SE, Kasanuki K, Hatano T, et al. (2012) Urinary Homocysteic Acid Levels Correlate with Mini-Mental State Examination Scores in Alzheimer’s Disease Patients. J Alzheimer’s Dis 31 59-64 [CrossRef] [Google Scholar] [PubMed]
  15. Hasegawa T, Mikoda N, Kitazawa M, LaFerla FM (2009) B6 deficient feeding or homocysteic acid induces the earlier Alzheimer’s pathological change in normal C57BL male mice. Nature Precedings [Google Scholar]
  16. Hasegawa T, Mikoda N, Kitazawa M, LaFerla FM (2010) Treatment of Alzheimer’s disease with anti-homocysteicacid antibody in 3xTg-AD male mice. PLoS One 5: e8593 [CrossRef] [Google Scholar] [PubMed]
  17. Hasegawa T, Ukai W, Jo DG, Xu X, Mattson MP, et al. (2005) Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: Implication for the pathogenesis of Alzheimer’s disease. J Neurosci Res 80: 869-876 [CrossRef] [Google Scholar] [PubMed]
  18. Miller RD, Monsul NT, Vender JR, Lehmann JC (136) NMDA- and endothelin-1-induced increases in blood-brain barrier permeability quantitated with Lucifer yellow. J Neurol Sci 136: 37-40 [CrossRef] [Google Scholar] [PubMed]
  19. Do KQ, Herrling PL, Streit P, Cuenod M (1988) Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor. J Neural Transm 2: 185-190 [CrossRef] [Google Scholar] [PubMed]
  20. Eichenbaum H (2004) Hippocampus: Cognitive Processes and Neural Representations that Underlie Declarative Memory. Neuron 44: 109-122 [CrossRef] [Google Scholar] [PubMed]